How Trump Could Benefit From A Possible ICE Contract
President Trump purchased $1-5 million in Axon Enterprise stock in February 2026, and two weeks later ICE announced a $220 million contract request to quadruple its taser inventory from the company Trump invested in. While the White House claims no conflict of interest and states Trump's trades are managed independently, the timing has drawn scrutiny from ethics experts and government watchdogs.
Summary
In May 2026, the US Office of Government Ethics released President Trump's financial disclosures for the first quarter of 2026, revealing nearly 3,700 transactions worth between $220-750 million, including stakes in companies regulated or contracted by his administration. Notably, Trump purchased between $1-5 million in shares of Axon Enterprise, the leading US taser manufacturer, on February 10, 2026. Exactly two weeks later, ICE announced it was seeking a 5-year, $220 million contract to increase its taser inventory from 4,300 to nearly 18,000 units. The White House responded that Trump acts in the best interest of the American public and maintains no conflict of interest, asserting that Trump's assets are managed by independent third-party firms with no Trump family involvement in selecting specific trades. However, experts identify Axon as the front-runner for the contract since the company manufactures tasers currently used by ICE and the agency's requirements match Axon's existing models. The contract remains unawarded as of the report, with no formal solicitation issued. The timing has drawn scrutiny from ethics experts and government watchdogs. Immigration enforcement context shows ICE detention has expanded significantly, from 37,000+ detainees in fiscal year 2024 to over 60,000 in April 2026. Axon reported record first-quarter 2026 revenue of over $800 million (up 34% year-over-year) and spent $2.4 million on lobbying in 2025, its largest lobbying expenditure in 24 years. The company's stock rose over 18% in the month following Trump's purchase. A procurement source indicated the contract may be stalled within DHS due to its size and timing, though the agency is expected to continue pursuing it.
Key Insights
- Trump purchased between $1-5 million in Axon Enterprise stock on February 10, 2026, and exactly 2 weeks later ICE announced a $220 million contract request to increase taser inventory from 4,300 to nearly 18,000 units from the same company
- Presidents are exempt from conflict of interest laws that apply to most other executive branch officials, providing legal cover for Trump's stock holdings in companies with government contracts
- ICE detention numbers have increased dramatically from 37,000+ detainees at the end of fiscal year 2024 to over 60,000 in April 2026, expanding the market for enforcement-related equipment like tasers
- Axon spent $2.4 million on lobbying Congress in 2025, the company's largest lobbying expenditure in 24 years, while simultaneously positioning itself for major government contracts
- A procurement source reports the ICE taser contract appears stalled inside DHS due to its size and timing, though the agency is expected to continue pursuing it
Topics
Transcript
[0:00] In May, the US Office of Government Ethics released President Trump's financial disclosures for the first 3 months of 2026. The president reported nearly 3,700 transactions in that period, including stakes and companies that his administration regulated or had contracts with. The transaction values were listed in ranges rather than exact amounts. But the first quarter trading spree was worth between $220 million and $750 million. The documents also revealed that the president bought up to $5 million in shares of a company called [0:30] Axon Enterprise, which is the top US taser maker. Exactly 2 weeks after Trump's purchase of the stock, ICE announced that it was seeking a 5-year, $220 million contract to more than quadruple its…
Full transcript available for MurmurCast members
Sign Up to AccessMore from CNBC
Why Trump Is Hitting Canada With 50% Tariffs
The Trump administration is imposing a 50% tariff on $20 billion worth of Canadian goods, primarily to gain leverage in trade negotiations and send a warning to other trading partners. This move is part of a broader strategy to address trade imbalances and contentious sectors like dairy and automotive industries.
How AI agents could transform retail investing
The advancement of AI agents in retail investing could lead to fully automated investment management, as firms develop solutions that customize strategies based on individual investor profiles. The industry is evolving from AI offering advice to AI executing trades on behalf of investors.
Why The U.S. Is Struggling To Keep Food Safe
The U.S. is experiencing the largest cyclospora outbreak in history, with over 10,000 cases reported. The inability to reliably trace contaminated food sources, exacerbated by federal funding cuts and the recent upheaval at the FDA, poses significant challenges for public health.
Who Makes The Elevators Americans Ride Every Day?
Otis, the world's largest elevator company, generates over $14 billion in annual revenue by servicing 2.5 million elevators globally, with over 90% of profits coming from maintenance and modernization rather than new installations. Despite strong long-term growth prospects driven by urbanization and infrastructure modernization, Otis has recently faced stock price headwinds due to service margin declines and China's weakened construction market.
Why Crypto Is Betting Big On AI Agents
The crypto industry is pivoting from targeting human users to focusing on AI agents as its next growth engine, with major companies like Circle, Kraken, and Coinbase building infrastructure for agents to autonomously manage wallets, execute trades, and make payments. Stablecoins and blockchain's always-on nature make crypto technically well-suited for machine-to-machine transactions that traditional banking cannot support, potentially creating a new stream of payment activity beyond speculation.